The National Institutes of Health has awarded $5.7 million for a five-year, multicenter study, which will be the first in the U.S. to evaluate the long-term outcomes of medical treatment for transgender youth.
Renowned researcher and educator Matthew Jacobson, PhD, has been named the new chair of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry.
Ion channel blockers, commonly used to treat cardiac, neurological and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UCSF scientists.
A systemwide task force of UC faculty, staff and administrators will develop a new set of retirement benefits options for UC employees hired on or after July 1, 2016 to comply with a new budget agreement.